- Home
- CCEL vs PRPO Comparison
CCEL vs PRPO Comparison
Compare CCEL & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CCEL | PRPO |
|---|---|---|
| Founded | 1989 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Managed Health Care | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.7M | 38.3M |
| IPO Year | 2022 | 2000 |
Fundamental Metrics
Financial Performance| Metric | CCEL | PRPO |
|---|---|---|
| Price | $4.51 | $20.78 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 9.9K | ★ 44.8K |
| Earning Date | 10-09-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 92.15 |
| EPS | ★ 0.23 | N/A |
| Revenue | ★ $25,384,279.00 | $24,049,000.00 |
| Revenue This Year | N/A | $233.72 |
| Revenue Next Year | N/A | $22.61 |
| P/E Ratio | $19.04 | ★ N/A |
| Revenue Growth | 9.76 | ★ 29.77 |
| 52 Week Low | $2.72 | $18.50 |
| 52 Week High | $4.90 | $33.63 |
Technical Indicators
Market Signals| Indicator | CCEL | PRPO |
|---|---|---|
| Relative Strength Index (RSI) | 53.80 | 30.21 |
| Support Level | $3.19 | $19.37 |
| Resistance Level | $4.76 | $24.54 |
| Average True Range (ATR) | 0.46 | 0.92 |
| MACD | 0.04 | -0.13 |
| Stochastic Oscillator | 70.41 | 5.17 |
Price Performance
Historical ComparisonAbout CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
About PRPO Precipio Inc.
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.